These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20588031)

  • 41. Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis.
    Sato F; Harpaz N; Shibata D; Xu Y; Yin J; Mori Y; Zou TT; Wang S; Desai K; Leytin A; Selaru FM; Abraham JM; Meltzer SJ
    Cancer Res; 2002 Feb; 62(4):1148-51. PubMed ID: 11861396
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
    D'Haens GR; Lashner BA; Hanauer SB
    Am J Gastroenterol; 1993 Aug; 88(8):1174-8. PubMed ID: 8338083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis.
    Biasco G; Zannoni U; Paganelli GM; Santucci R; Gionchetti P; Rivolta G; Miniero R; Pironi L; Calabrese C; Di Febo G; Miglioli M
    Cancer Epidemiol Biomarkers Prev; 1997 Jun; 6(6):469-71. PubMed ID: 9184782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis.
    Newell KJ; Matrisian LM; Driman DK
    Mol Carcinog; 2002 Jun; 34(2):59-63. PubMed ID: 12112311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of genomic instability in ulcerative colitis neoplasia leads to discovery of putative tumor suppressor regions.
    Chen R; Bronner MP; Crispin DA; Rabinovitch PS; Brentnall TA
    Cancer Genet Cytogenet; 2005 Oct; 162(2):99-106. PubMed ID: 16213356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia.
    AbdElazeem MA; El-Sayed M
    Ann Diagn Pathol; 2015 Dec; 19(6):369-74. PubMed ID: 26420348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
    Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunohistochemical analysis of the DNA methyltransferase 3b expression is associated with significant improvements in the discrimination of ulcerative colitis-associated neoplastic lesions.
    Ueda H; Tanaka H; Ichikawa K; Itabashi M; Kameoka S; Fujii S; Saito N; Kimura R; Shida Y; Fujimori Y; Ohtake S; Tomita S; Imura J; Yasuda Y; Tanigawa N; Uchiyama K; Fujimori T
    Surg Today; 2013 Nov; 43(11):1275-80. PubMed ID: 23307264
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
    Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
    J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
    Li Y; de Haar C; Chen M; Deuring J; Gerrits MM; Smits R; Xia B; Kuipers EJ; van der Woude CJ
    Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aberrant methylation of the Pleckstrin and Sec7 domain-containing gene is implicated in ulcerative colitis-associated carcinogenesis through its inhibitory effect on apoptosis.
    Okada S; Suzuki K; Takaharu K; Noda H; Kamiyama H; Maeda T; Saito M; Koizumi K; Miyaki Y; Konishi F
    Int J Oncol; 2012 Mar; 40(3):686-94. PubMed ID: 22002136
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene signature distinguishes patients with chronic ulcerative colitis harboring remote neoplastic lesions.
    Pekow J; Dougherty U; Huang Y; Gometz E; Nathanson J; Cohen G; Levy S; Kocherginsky M; Venu N; Westerhoff M; Hart J; Noffsinger AE; Hanauer SB; Hurst RD; Fichera A; Joseph LJ; Liu Q; Bissonnette M
    Inflamm Bowel Dis; 2013 Mar; 19(3):461-70. PubMed ID: 23388545
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microsatellite instability in inflamed and neoplastic epithelium in ulcerative colitis.
    Ishitsuka T; Kashiwagi H; Konishi F
    J Clin Pathol; 2001 Jul; 54(7):526-32. PubMed ID: 11429424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of ulcerative colitis and its associated colorectal neoplasia as a model of the organ-specific chronic inflammation-carcinoma sequence.
    Okayasu I
    Pathol Int; 2012 Jun; 62(6):368-80. PubMed ID: 22612505
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictive value of rectal aberrant crypt foci for intraepithelial neoplasia in ulcerative colitis - a cross-sectional study.
    Freire P; Figueiredo P; Cardoso R; Manuel Donato M; Ferreira M; Mendes S; Silva MR; Cipriano MA; Ferreira AM; Vasconcelos H; Portela F; Sofia C
    Scand J Gastroenterol; 2014 Oct; 49(10):1219-29. PubMed ID: 25157637
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Colorectal neoplasia in long-standing ulcerative colitis - a prospective study from a low-prevalence area.
    Shivakumar BM; Lakshmankumar B; Rao L; Bhat G; Suvarna D; Pai CG
    Colorectal Dis; 2013 Aug; 15(8):e462-8. PubMed ID: 23663532
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss of RUNX3 Immunoreactivity in Non-Neoplastic Rectal Mucosa May Predict the Occurrence of Ulcerative Colitis-Associated Colorectal Cancer.
    Shinagawa T; Hata K; Morikawa T; Matsunaga K; Emoto S; Murono K; Kaneko M; Sasaki K; Nishikawa T; Tanaka T; Kawai K; Nozawa H; Fukayama M; Ishihara S
    Digestion; 2020; 101(2):156-164. PubMed ID: 30763934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative analysis of copy number variations in ulcerative colitis associated and sporadic colorectal neoplasia.
    Shivakumar BM; Chakrabarty S; Rotti H; Seenappa V; Rao L; Geetha V; Tantry BV; Kini H; Dharamsi R; Pai CG; Satyamoorthy K
    BMC Cancer; 2016 Apr; 16():271. PubMed ID: 27080994
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of the Changes in Mitochondrial Gene Polymorphism in Ulcerative Colitis and the Etiology of Ulcerative Colitis-associated Colorectal Cancer.
    Tanaka T; Kobunai T; Yamamoto Y; Murono K; Emoto S; Hiyoshi M; Kaneko M; Sasaki K; Shuno Y; Nishikawa T; Hata K; Kawai K; Nozawa H; Ishihara S
    Anticancer Res; 2020 Jan; 40(1):101-107. PubMed ID: 31892558
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The sharp decline of beta estrogen receptors expression in long-lasting ulcerative-associated carcinoma.
    Principi M; Scavo MP; Piscitelli D; Villanacci V; Lovero R; Losurdo G; Girardi B; Ierardi E; Di Leo A
    Scand J Gastroenterol; 2015 Aug; 50(8):1002-10. PubMed ID: 25862314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.